SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001267602-21-000041
Filing Date
2021-08-13
Accepted
2021-08-13 08:16:46
Documents
14
Period of Report
2021-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alim-20210813x8k.htm   iXBRL 8-K 75496
2 EX-99.1 alim-20210813xex99_1.htm EX-99.1 373424
3 GRAPHIC alim-20210813xex99_1g001.jpg GRAPHIC 23407
  Complete submission text file 0001267602-21-000041.txt   630444

Data Files

Seq Description Document Type Size
4 EX-101.SCH alim-20210813.xsd EX-101.SCH 2217
5 EX-101.LAB alim-20210813_lab.xml EX-101.LAB 18505
6 EX-101.PRE alim-20210813_pre.xml EX-101.PRE 11438
7 EXTRACTED XBRL INSTANCE DOCUMENT alim-20210813x8k_htm.xml XML 4824
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 211169824
SIC: 2834 Pharmaceutical Preparations